Unlock instant, AI-driven research and patent intelligence for your innovation.
Heterocyclic sulfonamide derivatives and medicines containing them
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A drug and pharmaceutical technology applied in the field of novel heterocyclic sulfonamide compounds
Active Publication Date: 2022-05-13
EA PHARMA CO LTD
View PDF14 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
In addition, it has also been reported that formaldehyde-induced pain behavior disappears in TRPA1 knockout mice (Non-Patent Document 9)
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0721] Hereinafter, the present invention will be described in detail using reference examples, examples, and test examples, but the present invention is not limited to these. In addition, unless otherwise specified, the devices, reagents, and the like used in this example can be easily prepared according to methods generally practiced in the art, or can be purchased commercially. In addition, % of the title compound represents a yield.
[0722] The structural formulas and physical properties of the reference example compounds are shown in Table 2.
[0723] [table 2-1]
[0724]
[0725] [Table 2-2]
[0726]
[0727] [Table 2-3]
[0728]
[0729] [Table 2-4]
[0730]
[0731] [Table 2-5]
[0732]
reference example A-1
[0733] Reference Example A-1: Synthesis of 5-fluorobenzofuran-2-ylsulfonyl chloride (A-1)
[0734] (Step 1) Synthesis of 2-(2,2-dibromovinyl)-4-fluorophenol
[0735] A solution of carbon tetrabromide (1.70kg, 5.14mol) in dichloromethane (80mL) was cooled to 0°C, triphenylphosphine (2.07kg, 7.91mol) was added, and stirred for 30 minutes. Triethylamine (1.30 kg, 12.8 mol) was added to the reaction mixture, and then 5-fluoro-2-hydroxybenzaldehyde (300 g, 2.14 mol) was added slowly while keeping the reaction temperature below 5°C. The reaction mixture was stirred at 30°C for 2 hours, then concentrated under reduced pressure, and the resulting residue was purified by silica gelcolumn chromatography (hexane / ethyl acetate) to obtain the title compound (300 g, 1.01 mol, 47%).
[0744] Reference Example A-2: Synthesis of 4-fluorobenzofuran-2-ylsulfonyl chloride (A-2)
[0745] The title compound was obtained by the same procedure as in Reference Example A-1, using 6-fluoro-2-hydroxybenzaldehyde instead of 5-fluoro-2-hydroxybenzaldehyde.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The object of the present invention is to provide a novel compound with TRPAl antagonistic activity, a drug containing the compound, a TRPAl antagonist and a drug which may be used to prevent or treat diseases related to TRPAl. The compound represented by formula (I) or its pharmaceutically acceptable salt, and the medicines containing it have TRPAl antagonistic activity, and may be used for TRPAl antagonists and the prevention or treatment of diseases related to TRPA1. In the formula, each symbol has the same meaning as in the description.
Description
technical field [0001] The present invention relates to a novel heterocyclic sulfonamide compound with transient receptor potential ankyrin 1 (Transient Receptor Potential Ankyrin 1, TRPA1) antagonistic activity and a pharmaceutical composition containing the compound, and may be used for the prevention or treatment of diseases related to TRPA1 medicine. Background technique [0002] Transient receptor potential ankyrin 1 (TRPA1) is a non-selective cation channel belonging to the transient receptor potential (TRP) channel superfamily. Like other TRP channel families, it has 6 transmembrane domains forming a tetramer composed of 4 subunits. TRPA1 is a ligand-dependent ion channel that undergoes structural changes through ligand binding. As a result, the channel opens, allowing cations such as calcium ions and sodium ions to flow into the cell, thereby regulating the membrane potential of the cell. As ligands of TRPA1, irritating natural substances (for example, allyl isoth...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.